ABRILADA Trademark

Trademark Overview

On Thursday, October 1, 2020, a trademark application was filed for ABRILADA with the United States Patent and Trademark Office. The USPTO has given the ABRILADA trademark a serial number of 90229278. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Pfizer Inc.. The ABRILADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis
abrilada

General Information

Serial Number90229278
Word MarkABRILADA
Filing DateThursday, October 1, 2020
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7279703
Registration DateTuesday, January 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 16, 2020
Primary Code005
First Use Anywhere DateWednesday, October 18, 2023
First Use In Commerce DateWednesday, October 18, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, October 5, 2020NEW APPLICATION ENTERED
Monday, November 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 26, 2021ASSIGNED TO EXAMINER
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 15, 2021SOU TEAS EXTENSION RECEIVED
Monday, November 15, 2021SOU EXTENSION 1 FILED
Monday, November 15, 2021SOU EXTENSION 1 GRANTED
Wednesday, November 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, May 12, 2022SOU EXTENSION 2 FILED
Thursday, May 12, 2022SOU EXTENSION 2 GRANTED
Saturday, May 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 9, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 9, 2022SOU EXTENSION 3 FILED
Wednesday, November 9, 2022SOU EXTENSION 3 GRANTED
Friday, November 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 1, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 1, 2023SOU EXTENSION 4 FILED
Monday, May 1, 2023SOU EXTENSION 4 GRANTED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 21, 2023USE AMENDMENT FILED
Tuesday, November 21, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, December 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, December 11, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 12, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

abrilada pharmaceutical disorders treatment preparations skin arthritis inflammatory autoimmune diseases